Jeanne Marie Evans focuses her practice on mergers and acquisitions as well as regulatory, compliance and operational issues for healthcare companies. She works with a range of the firm’s healthcare clients, including hospitals and health systems, physician practice management companies, specialty pharmacies, private equity firms, health plan providers, and others. More specifically, Jeanne Marie’s practice involves:
Prior to joining Bass, Berry & Sims, Jeanne Marie was an associate at Kutak Rock LLP in Missouri where she provided regulatory guidance to healthcare clients. Jeanne Marie earned her law degree with a Certificate of Health Law from Saint Louis University School of Law and received a B.A. in history and communication studies from Loyola University of Chicago.
American Health Law Association (AHLA)
American Bar Association
Nashville Young Leaders Council – Alumnus
Representation of J. Knipper and Company, Inc. – one of the largest suppliers of end-to-end pharmaceutical samples management services and a Court Square portfolio company – and its affiliates, including KnippeRx, in its acquisition of Eagle Pharmacy – a Florida-based full-service, direct-to-patient (DTP) pharmacy. This strategic transaction for KnippeRx will expand the company’s pharmacy programs, scale and automation capabilities.
Representation of Linden Capital Partners, as lead healthcare regulatory counsel, in its investment in Vital Care, Inc., a pharmacy franchisor of home infusion services. Linden Capital Partners is a Chicago-based private equity firm focused exclusively on the healthcare industry
Representation of Triage Consulting Group, a healthcare revenue integrity company in its acquisition by Revint Solutions, a leader in technology-enabled revenue integrity solutions for healthcare providers
Representation of Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, in its sale of certain assets of Passport Health Plan, including Passport’s brand, operational and clinical infrastructure, and certain provider and vendor agreements, to Molina Healthcare, Inc.
Served as regulatory and deal counsel to BioPlus, a leading national specialty pharmacy, and ProHealth Pharmacy Solutions, a significant provider of infusion pharmacy management services in their sale to CarepathRx a platform company formed by Nautic Partners
Representation of WellCare Health Plans, Inc., a government-focused managed care provider, in its merger with Centene Corporation (NYSE: CNC) for $17.3 billion
Representation of LucidHealth, a portfolio company of Excellere Partners, in its acquisition of Madison Radiologists
Representation of Clearway Pain Solutions, an interventional pain management medical practice that is backed by NexPhase, in its merger with KureSmart Pain Management
We represented BioScrip, Inc. in its merger with Option Care Enterprises, Inc. The newly combined company, Option Care Health, Inc., emerges as the largest independent home and alternate site infusion services provider in the United States. Option Care Health’s common stock will be listed on the Nasdaq Global Select Market under the ticker symbol BIOS.
Saint Louis University Journal of Health Law and Policy — Lead Editor (2014-2015), Staff Editor (2013-2014)
Saint Louis University School of Law — Academic Excellence Award: Health Law; FDA Law and Policy; Fraud, Abuse and Healthcare; and Commercial Transactions